{"created":"2023-05-15T09:07:00.376898+00:00","id":14218,"links":{},"metadata":{"_buckets":{"deposit":"460a2cc4-bf42-4e25-941d-f46d83d7a572"},"_deposit":{"created_by":15,"id":"14218","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"14218"},"status":"published"},"_oai":{"id":"oai:sapmed.repo.nii.ac.jp:00014218","sets":["1658:1661:1712"]},"author_link":["23674","23675","23676","23677","23678","23679"],"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1997","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"31","bibliographicPageStart":"23","bibliographicVolumeNumber":"32","bibliographic_titles":[{"bibliographic_title":"Tumor Research"},{"bibliographic_title":"Tumor Research","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Thirty-five patients were analyzed in this study to elucidate the usefulness of adjuvant chemotherapy by continuous infusion of 5-fluorouracil plus daily low-dose cisplatin after resection in advanced (stage IV) pancreatic cancer. The patients were divided into 3 groups : 8 patients were treated with the above therapy (group A), 16 patients with conventional chemotherapy (group B), and 11 patients received no chemotherapy whatsoever (group C). Mean survival time was longer in group A than in group B and C. These results were remarkable given that the patients had been diagnosed as stage IVb and curability C. Al-though the occurrence of adverse effects was higher in group A, none of them were severe. We conclude in this retrospective study that continuous infusion of 5-fluorouracil plus daily low-dose cisplatin is effective adjuvant chemotherapy in the treatment of advanced cancer of the pancreas. Therefore, the prospective trial will be necessary in near future.","subitem_description_type":"Abstract"}]},"item_7_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.15114/tr.32.23","subitem_identifier_reg_type":"JaLC"}]},"item_7_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Sapporo Medical University"}]},"item_7_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0041-4093","subitem_source_identifier_type":"ISSN"}]},"item_7_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Oikawa, Ikuo"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Hirata, Koichi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Hata, Fumitake"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Katsuramaki, Tadashi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Mukaiya, Mitsuhiro"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sasaki, Kazuaki"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-07-31"}],"displaytype":"detail","filename":"n004140933223.pdf","filesize":[{"value":"332.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"n004140933223.pdf","url":"https://sapmed.repo.nii.ac.jp/record/14218/files/n004140933223.pdf"},"version_id":"de8c0642-fd84-48b9-8fc8-e0bb09135f9c"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"5-fluorouracil","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Cisplatin","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Biochemical modulation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Advanced pancreatic cancer","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Is adjuvant chemotherapy by continuous infusion 5-fluorouracil plus daily low dose cisplatin useful in advanced (stageIV) pancreatic cancer ?","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Is adjuvant chemotherapy by continuous infusion 5-fluorouracil plus daily low dose cisplatin useful in advanced (stageIV) pancreatic cancer ?","subitem_title_language":"en"}]},"item_type_id":"7","owner":"15","path":["1712"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2019-07-31"},"publish_date":"2019-07-31","publish_status":"0","recid":"14218","relation_version_is_last":true,"title":["Is adjuvant chemotherapy by continuous infusion 5-fluorouracil plus daily low dose cisplatin useful in advanced (stageIV) pancreatic cancer ?"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2023-12-13T02:44:43.076531+00:00"}